Acumen Pharmaceuticals, Inc. (ABOS)
2.16
-0.01
(-0.46%)
USD |
NASDAQ |
Dec 24, 16:00
Acumen Pharmaceuticals Free Cash Flow: -123.74M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Black Diamond Therapeutics, Inc. | 21.35M |
| Pulmonx Corp. | -32.64M |
| NovaBay Pharmaceuticals, Inc. | -7.012M |
| Palatin Technologies, Inc. | -15.91M |
| Theriva Biologics, Inc. | -18.51M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -30.49M |
| Cash from Investing (Quarterly) | 40.51M |
| Free Cash Flow Per Share (Quarterly) | -0.5033 |
| Free Cash Flow to Equity (Quarterly) | -31.22M |
| Free Cash Flow to Firm (Quarterly) | -29.42M |
| Free Cash Flow Yield | -94.78% |